Tumor heterogeneity affects the activity of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in EGFR mutant non-small cell lung cancer (NSCLC) patients (pts)
N. Normanno
◽
A.M. Rachiglio
◽
M. Lambiase
◽
F. Fenizia
◽
A. Iannaccone
◽
...
2016 ◽
Vol 27
◽
pp. vi427
N. Normanno
◽
A.M. Rachiglio
◽
M. Lambiase
◽
F. Fenizia
◽
A. Iannaccone
◽
...
2018 ◽
Vol 6
(8)
◽
pp. 140-140
◽
2015 ◽
Vol 26
◽
pp. ix125
N. Tsushita
◽
Y. Goto
◽
H. Shiraishi
◽
K. Tsuruoka
◽
K. Yoshida
◽
...
2007 ◽
Vol 2
(8)
◽
pp. S509
2019 ◽
Vol 30
◽
pp. v630-v631
K. Yonesaka
◽
E. Iwama
◽
H. Hayashi
◽
S. Suzuki
◽
R. Kato
◽
...
2021 ◽
Vol 16
(4)
◽
pp. S770-S771
J. Subramanian
◽
Y-L. Choi
◽
T-Y. Chou
◽
J. Gregg
◽
R. Hui
◽
...
Jun Li
◽
Zhao Chen
◽
Daqiang Sun
◽
Meilin Xu
◽
Xun Zhang
◽
...
2020 ◽
Vol 28
(3)
◽
pp. 351-363
Hsin-Yi Wang
◽
Yi-Nan Liu
◽
Shang-Gin Wu
◽
Chia-Lang Hsu
◽
Tzu-Hua Chang
◽
...
2015 ◽
Vol 87
(3)
◽
pp. 311-317
◽
Chang Dong Yeo
◽
Ki Hoon Park
◽
Chan Kwon Park
◽
Sang Haak Lee
◽
Seung Joon Kim
◽
...
M. Bonomi
◽
L. Bonomi
◽
M.G. Sauta
◽
A.C. Bettini
◽
M. Squadroni
◽
...